Skip to main content

Editorial Board

Editors-in-Chief
Michael Pollak, MD, McGill University and Lady Davis Research Institute, Canada
Matthew Vander Heiden, MD, PhD, Massachusetts Institute of Technology, USA

Deputy Editor
Costas Lyssiotis, PhD, University of Michigan, USA

Editor Emeritus
Chi Van Dang, PhD, Abramson Cancer Centre, University of Pennsylvania, USA

Associate Editors:
Celia R. Berkers, PhD, Utrecht University, Netherlands
Kivanc Birsoy, PhD, The Rockefeller University, USA
Kevin Brindle, PhD, University of Cambridge, UK
Navdeep Chandel, PhD, Northwestern University, USA
Maralice Conacci Sorrell, PhD, University of Texas Southwestern Medical Center, USA
Lydia Finley, PhD, Memorial Sloan Kettering Cancer Center, USA 
Christian Frezza, PhD, University Hospital Cologne, Germany
Peng Huang, PhD, Sun Yat-sen University, Guangzhou, China
Richard G. Kibbey, MD, PhD, Yale University School of Medicine, USA
Mioara Larion, PhD, National Cancer Institute, Center for Cancer Research, National Institutes of Health, USA
Fuming Li, PhD, Fudan University, Shanghai, China
Christian Metallo, PhD, Salk Institute for Biological Studies, USA
Andrea Morandi, PhD, Universit√† degli Studi di Firenze, Italy
Dr. Wilhelm Palm, German Cancer Research Center, Heidelberg, Germany
Rachel Perry, PhD, Yale University School of Medicine, USA
Katerina Rohlenova, PhD, Institute of Biotechnology of the Czech Academy of Sciences, Czech Republic
Julie St-Pierre, PhD, University of Ottawa, Canada
Daniel TennantPhD, University of Birmingham, UK
Oana Zeleznik , PhD, Harvard University, USA
Wei-Xing ZongPhD, Rutgers University, USA

Editorial Board Members:
Abass Alavi, MD, PhD, University of Pennsylvania School of Medicine, USA
Lewis Cantley, PhD, Weill Cornell Medical College, USA
Peter Carmeliet, MD, PhD, Vesalius Research Center, Belgium
Gina DeNicola, PhD, Moffitt Cancer Center, USA
Robert Gatenby, MD, Moffitt Cancer Center, USA
Kun-Liang Guan, PhD, University of  California, USA
Sophia Lunt, PhD, Michigan State University, USA
Gordon Mills, MD, PhD, University of Texas M. D. Anderson Cancer Center, USA
Michael E Pacold, MD, PhD, New York University Langone Health, USA
Thales Pappagiannokopoulos, PhD, NYU Grossman School of Medicine, USA
Jacques Pouyssegur, PhD, Institute of Research on Cancer and Aging, France
Joshua Rabinowitz, PhD, Princeton University, USA
Sir Peter Ratcliffe, MD, University of Oxford AND The Francis Crick Institute, UK
Jeffrey Rathmell, PhD, Duke University, USA
Jared Rutter, PhD, University of Utah School of Medicine, USA
Celeste Simon, PhD, University of Pennsylvania Perelman School of Medicine, USA
Bert Vogelstein, MD, Johns Hopkins University School of Medicine, USA
Karen Vousden, PhD, Francis Crick Institute, UK
Eileen White, PhD, The Cancer Institute of New Jersey, USA

Annual Journal Metrics

  • 2022 Citation Impact
    5.9 - 2-year Impact Factor
    6.3 - 5-year Impact Factor

    2023 Speed
    19 days submission to first editorial decision for all manuscripts (Median)
    149 days submission to accept (Median)

    2023 Usage
    398,435 downloads
    311 Altmetric mentions

Springer Nature Oncology Portfolio

Discover the range of academic oncology titles at Springer Nature here.